Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women

• Egile Nagusiak: Stuart J. Moat (Egilea), Sharon Hillier (Egilea), Sikha de Souza (Egilea), Malorie Perry (Egilea), Simon Cottrell (Egilea), Alex Lench (Egilea), Heather Payne (Egilea), Stephen Jolles (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

SARS-CoV-2 vaccine uptake in pregnant women is believed to be low and lags behind the general population contributing to increased hospital admissions, and poor maternal and fetal outcomes. However, there is a paucity of information on the SARS-CoV-2 serostatus of pregnant women to help inform polic...